Chongqing Biocare Pharmaceutical Ltd.
FDA inspection history in Chongqing, China, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Chongqing, China.
Cited most
Across all Chongqing Biocare Pharmaceutical observations on file
- 21 CFR 211.58Maintenance2
- 21 CFR 211.42Design and construction features1
The complete Chongqing Biocare Pharmaceutical file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Chongqing, China
One Form 483 · 2023
Latest: Form 483, Sep 22, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-09-22 | 483 Form 483 | Chongqing, China | — | $99 |
Investigators on these documents
FEI number 3006305268 · most recent document Sep 22, 2023
About Chongqing Biocare Pharmaceutical Ltd.
How many FDA Form 483s has Chongqing Biocare Pharmaceutical Ltd. received?
FDA Intel has 1 Form 483 on file for Chongqing Biocare Pharmaceutical Ltd.; the most recent is dated Sep 22, 2023.
When was Chongqing Biocare Pharmaceutical Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Chongqing Biocare Pharmaceutical Ltd. is a Form 483 dated Sep 22, 2023, for the site in Chongqing, China.
What did FDA cite at Chongqing Biocare Pharmaceutical Ltd.?
The regulations cited most in the observations on file for Chongqing Biocare Pharmaceutical Ltd. are 21 CFR 211.58 (Maintenance), 2 times; 21 CFR 211.42 (Design and construction features), 1 time.